Free Trial

Jamieson Wellness (TSE:JWEL) Stock Price Down 0.6% - Should You Sell?

Jamieson Wellness logo with Consumer Defensive background

Key Points

  • Jamieson Wellness shares fell by 0.6% to C$36.90, with trading volume significantly exceeding the average by 165% during the session.
  • Analyst reports have generally been positive, with multiple firms upgrading their price targets, resulting in a consensus rating of "Buy" and an average target price of C$42.40.
  • Recent insider transactions revealed substantial share sales by inside owners, suggesting changes in equity holdings and confidence among company leadership.
  • Five stocks to consider instead of Jamieson Wellness.

Jamieson Wellness Inc. (TSE:JWEL - Get Free Report) dropped 0.6% during mid-day trading on Wednesday . The company traded as low as C$36.20 and last traded at C$36.90. Approximately 186,452 shares changed hands during trading, an increase of 165% from the average daily volume of 70,381 shares. The stock had previously closed at C$37.13.

Analyst Upgrades and Downgrades

JWEL has been the subject of a number of recent analyst reports. National Bankshares raised their price target on shares of Jamieson Wellness from C$40.00 to C$40.60 and gave the stock an "outperform" rating in a report on Friday, August 8th. TD Securities increased their price objective on shares of Jamieson Wellness from C$42.00 to C$45.00 and gave the stock a "buy" rating in a research report on Friday, August 8th. Finally, BMO Capital Markets raised their price target on shares of Jamieson Wellness from C$41.00 to C$42.00 and gave the company an "outperform" rating in a research report on Friday, August 8th. Four equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of C$42.40.

View Our Latest Stock Report on JWEL

Jamieson Wellness Trading Down 0.6%

The firm has a market capitalization of C$1.54 billion, a PE ratio of 27.74 and a beta of 1.29. The company's 50-day moving average price is C$36.13 and its 200-day moving average price is C$34.06. The company has a debt-to-equity ratio of 75.70, a quick ratio of 1.08 and a current ratio of 2.76.

Insider Transactions at Jamieson Wellness

In other Jamieson Wellness news, insider Paul Michael Galbraith sold 7,905 shares of Jamieson Wellness stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of C$36.50, for a total value of C$288,510.37. Following the transaction, the insider directly owned 5,366 shares in the company, valued at approximately C$195,843.98. The trade was a 59.57% decrease in their ownership of the stock. Also, insider Christopher Snowden sold 106,852 shares of Jamieson Wellness stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of C$36.03, for a total transaction of C$3,850,198.12. Following the completion of the transaction, the insider owned 172,021 shares in the company, valued at approximately C$6,198,432.69. This represents a 38.32% decrease in their ownership of the stock. 0.26% of the stock is currently owned by insiders.

About Jamieson Wellness

(Get Free Report)

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Jamieson Wellness Right Now?

Before you consider Jamieson Wellness, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list.

While Jamieson Wellness currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.